BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 25596268)

  • 1. BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.
    de Rooij JD; van den Heuvel-Eibrink MM; Hermkens MC; Verboon LJ; Arentsen-Peters ST; Fornerod M; Baruchel A; Stary J; Reinhardt D; de Haas V; Pieters R; Zwaan CM
    Haematologica; 2015 May; 100(5):e194-5. PubMed ID: 25596268
    [No Abstract]   [Full Text] [Related]  

  • 2. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
    Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Saito R; Furuta Y; Miyadera K; Tokura T; Marumo A; Omori I; Sakaguchi M; Fujiwara Y; Yui S; Ryotokuji T; Arai K; Kitano T; Wakita S; Fukuda T; Inokuchi K
    Genes Chromosomes Cancer; 2018 Aug; 57(8):401-408. PubMed ID: 29663558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
    Coskun FR; Percin-Pacal F; Emrence Z; Ar MC; Abaci N; Unuvar A; Eskazan AE; Elverdi T; Salihoglu A; Seflekci Y; Karakas Z; Soysal T; Sirma-Ekmekci S
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarifying the impact of polycomb complex component disruption in human cancers.
    Yamamoto Y; Abe A; Emi N
    Mol Cancer Res; 2014 Apr; 12(4):479-84. PubMed ID: 24515802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The corepressors BCOR and BCORL1: two novel players in acute myeloid leukemia.
    Tiacci E; Grossmann V; Martelli MP; Kohlmann A; Haferlach T; Falini B
    Haematologica; 2012 Jan; 97(1):3-5. PubMed ID: 22210327
    [No Abstract]   [Full Text] [Related]  

  • 6. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
    Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
    Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia.
    Honda A; Koya J; Yoshimi A; Miyauchi M; Taoka K; Kataoka K; Arai S; Kurokawa M
    Exp Hematol; 2021 Sep; 101-102():42-48.e11. PubMed ID: 34333045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].
    Cen YX; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2004-2010. PubMed ID: 33283733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
    Lindsley RC; Mar BG; Mazzola E; Grauman PV; Shareef S; Allen SL; Pigneux A; Wetzler M; Stuart RK; Erba HP; Damon LE; Powell BL; Lindeman N; Steensma DP; Wadleigh M; DeAngelo DJ; Neuberg D; Stone RM; Ebert BL
    Blood; 2015 Feb; 125(9):1367-76. PubMed ID: 25550361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV6 mutations and loss in AML-M0.
    Silva FP; Morolli B; Storlazzi CT; Zagaria A; Impera L; Klein B; Vrieling H; Kluin-Nelemans HC; Giphart-Gassler M
    Leukemia; 2008 Aug; 22(8):1639-43. PubMed ID: 18305557
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Abuhadra N; Mukherjee S; Al-Issa K; Adema V; Hirsch CM; Advani A; Przychodzen B; Makhoul A; Awada H; Maciejewski JP; Sekeres MA; Nazha A
    Leuk Lymphoma; 2019 Jun; 60(6):1587-1590. PubMed ID: 30618304
    [No Abstract]   [Full Text] [Related]  

  • 12. BCOR/BCORL1 mutated hypergranular cells mimicking acute promyelocytic leukemia.
    Lebecque B; Dannus LT
    Blood; 2023 May; 141(18):2283. PubMed ID: 37140950
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence and prognostic significance of c-KIT mutations in core binding factor acute myeloid leukemia: a comprehensive large-scale study from a single Chinese center.
    Qin YZ; Zhu HH; Jiang Q; Jiang H; Zhang LP; Xu LP; Wang Y; Liu YR; Lai YY; Shi HX; Jiang B; Huang XJ
    Leuk Res; 2014 Dec; 38(12):1435-40. PubMed ID: 25449688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor.
    Pettirossi V; Venanzi A; Spanhol-Rosseto A; Schiavoni G; Santi A; Tasselli L; Naccari M; Pensato V; Pucciarini A; Martelli MP; Drexler H; Falini B; Tiacci E
    Leukemia; 2023 Feb; 37(2):473-477. PubMed ID: 36635390
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
    Tokumasu M; Murata C; Shimada A; Ohki K; Hayashi Y; Saito AM; Fujimoto J; Horibe K; Nagao M; Itoh H; Kamikubo Y; Nakayama H; Kinoshita A; Tomizawa D; Taga T; Tawa A; Tanaka S; Heike T; Adachi S
    Leukemia; 2015 Dec; 29(12):2438-41. PubMed ID: 25975190
    [No Abstract]   [Full Text] [Related]  

  • 16. High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.
    Grossmann V; Schnittger S; Poetzinger F; Kohlmann A; Stiel A; Eder C; Fasan A; Kern W; Haferlach T; Haferlach C
    Leukemia; 2013 Sep; 27(9):1933-6. PubMed ID: 23535558
    [No Abstract]   [Full Text] [Related]  

  • 17. Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia.
    Park SH; Chi HS; Min SK; Park BG; Jang S; Park CJ
    Leuk Res; 2011 Oct; 35(10):1376-83. PubMed ID: 21715005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NPM1, FLT3, and c-KIT mutations in pediatric acute myeloid leukemia in Russian population.
    Yatsenko Y; Kalennik O; Maschan M; Kalinina I; Maschan A; Nasedkina T
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):e100-8. PubMed ID: 23511494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mutations in the transcriptional corepressor gene BCORL1 in adult acute myelogenous leukemia.
    Li M; Collins R; Jiao Y; Ouillette P; Bixby D; Erba H; Vogelstein B; Kinzler KW; Papadopoulos N; Malek SN
    Blood; 2011 Nov; 118(22):5914-7. PubMed ID: 21989985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KIT D816 mutation associates with adverse outcomes in core binding factor acute myeloid leukemia, especially in the subgroup with RUNX1/RUNX1T1 rearrangement.
    Kim HJ; Ahn HK; Jung CW; Moon JH; Park CH; Lee KO; Kim SH; Kim YK; Kim HJ; Sohn SK; Kim SH; Lee WS; Kim KH; Mun YC; Kim H; Park J; Min WS; Kim HJ; Kim DH;
    Ann Hematol; 2013 Jan; 92(2):163-71. PubMed ID: 23053179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.